Current management of cytomegalovirus infection: treatment and prophylaxis.
Hardy
D
D
University of California, Los Angeles, School of Medicine 90095, USA.
D000284:Administration, Oral; D000900:Anti-Bacterial Agents; D000998:Antiviral Agents / Q000627:therapeutic use*; D003587:Cytomegalovirus; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D017245:Foscarnet / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D012008:Recurrence
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D017245:Foscarnet; D015774:Ganciclovir